ARK Genomic Revolution ETF
ARKG
ARKG
261 hedge funds and large institutions have $536M invested in ARK Genomic Revolution ETF in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 55 increasing their positions, 93 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
261
Holders Change
-22
Holders Change %
-7.77%
% of All Funds
3.8%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
55
Reduced
93
Closed
46
Calls
$98.4M
Puts
$167M
Net Calls
-$68.5M
Net Calls Change
+$2.49M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$53M |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$34.2M |
| 3 |
3
Goldman Sachs
New York
|
$21.3M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$41M |
| 5 |
GS
5
GTS Securities
New York
|
$7.44M |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$36.1M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$285K |
| 3 |
LC
3
Longitude (Cayman)
Grand Cayman,
Cayman Islands
|
$0 |
| 4 |
4
Two Sigma Investments
New York
|
$2.78M |
| 5 |
5
Citigroup
New York
|
$19.5M |
